Indian journal of Medical Biochemistry

Register      Login

VOLUME 21 , ISSUE 1 ( January-June, 2017 ) > List of Articles

ORIGINAL ARTICLE

Study of Oxidative Stress Status in Relation to Glycemic Index Fluctuations in Type II Diabetes Mellitus Patients

Shazia Arafeen, Madhumita Chatterjee

Citation Information : Arafeen S, Chatterjee M. Study of Oxidative Stress Status in Relation to Glycemic Index Fluctuations in Type II Diabetes Mellitus Patients. Indian J Med Biochem 2017; 21 (1):49-53.

DOI: 10.5005/jp-journals-10054-0019

License: CC BY 3.0

Published Online: 01-06-2017

Copyright Statement:  Copyright © 2017; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Background

Oxidative stress is characterized by an increased generation of O2-derived molecules called reactive oxygen species that provoke critical, even irreversible, cell injury.

Aim

To evaluate oxidative stress status through measurement of malondialdehyde (MDA) and to analyze association of changes in MDA status with respect to fluctuations in glycemic control.

Materials and methods

A total of 112 subjects, both males and females, aged above 30 years were enrolled for this study, in which 81 had type II diabetes and 31 were without diabetes. Random blood sugar (RBS) was measured by glucose oxidase and peroxidase method. Serum MDA was measured by thiobarbituric acid reactive substances method. Glycated hemoglobin (HbA1c) was measured by ion exchange resin method.

Results

The MDA and HbA1c levels were increased in diabetics and were statistically significant. In all the studied groups, MDA was positively correlated with RBS and HbA1c.

Conclusion and clinical significance

The study suggests that MDA should be measured along with routine parameters of disease and the use of redox active antioxidants to tone down MDA levels may be evaluated to contribute in early and improvised clinical management of type II diabetes mellitus and also to delay the development of secondary complications of the disease.

How to cite this article

Arafeen S, Chatterjee M. Study of Oxidative Stress Status in Relation to Glycemic Index Fluctuations in Type II Diabetes Mellitus Patients. Indian J Med Biochem 2017;21(1):49-53.


  1. ; Krall, LP. Joslin's diabetes mellitus. Kahn CR, Weir GC, King GL, Jacobson AM, Moses AC, Smith RJ, editors. (Spanish edition). New York (NY): Lippincott, Williams and Wilkins; 2007.
  2. Hyperuricemia, high serum urea and hypoproteinemia are the risk factor for diabetes. Asian J Med Sci 2009 Sep;1(2):33–34.
  3. Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control. Arch Med Res 2001 Jul-Aug;32(4):283–287.
  4. The effects of diabetes mellitus, age, and vitamin E on testicular oxidative stress. Fertil Steril 2007 Jun;90(3):755–760.
  5. Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N Engl J Med 1976 Aug;295(8):417–420.
  6. Diabetes and advanced glycoxidation end products. Diabetes Care 2006 Jun;29(6):1420–1432.
  7. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes. Diabetes Care 2009 Jul;32(7):1327–1334.
  8. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011 Jan;34(Suppl 1):S62–S69.
  9. American College of Endocrinology Statement on the use of hemoglobin A1c for the diagnosis of diabetes. Endocr Pract 2010 Mar;16(2):155–156.
  10. 2011 [cited 2016 Sep]. Available from: http://www.who.int/cardiovascular_diseases/reporthba1c_2011_edited.pdf.
  11. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006 Apr;440:944–948.
  12. Association of oxidative stress, insulin resistance, and diabetes risk phenotypes. Diabetes Care 2007 Oct;30(10):2529–2535. Available from: http://dx.doi.org/10.2337/dc07-0817.
  13. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003 Feb;17(1):24–38.
  14. Ch SLV, Surya Prakash G, Seshadri Reddy V, Arul Murugan S. Evaluation of oxidative stress presented in patients with diabetes mellitus and metabolic syndrome. J Curr Trends Clin Med Lab Biochem 2014 Jan-Mar;2(1):33–38.
  15. Serum nitrite levels in relation to malondialdehyde in type 2 diabetes mellitus. Recent Res Sci Technol 2012;4(6):11–12.
  16. Lipid profile, serum malondialdehyde, superoxide dismutase in chronic kidney diseases and Type 2 diabetes mellitus. Biomed Res 2012 Feb;23(2):207–210.
  17. Proxidant and antioxidant status in type 2 diabetes with relation to its duration. Int J Pharma Bio Sci 2011 Apr-Jun;2(2):386–391.
  18. Evaluation of the thyroid status, oxidant stress and antioxidant status in patients with type-2 diabetes mellitus. J Clin Diagn Res 2011 Apr;5(2):254–256.
  19. Evaluation of oxidative stress in type 2 diabetes mellitus and follow-up along with vitamin E supplementation. Ind J Clin Biochem 2011 Jan-Mar;26(1):74–77.
  20. Oxidative stress, antioxidant status and lipid profile in the saliva of type 2 diabetics. Diab Vasc Dis Res 2011 Jan;8(1):22–28.
  21. Malondialdehyde and trace element levels in patients with type 2 diabetes mellitus. Arch Hell Med 2011 Jan;28(1):83–88.
  22. Type 2 diabetes mellitus duration: an independent predictor of serum malondialdehyde levels. Singapore Med J 2010 Jul;51(7):582–585.
  23. Oxidative stress in diabetes mellitus. Romanian J Biophys 2008 Jun;18(3):225–236, Bucharest.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.